<code id='3AC33DBE57'></code><style id='3AC33DBE57'></style>
    • <acronym id='3AC33DBE57'></acronym>
      <center id='3AC33DBE57'><center id='3AC33DBE57'><tfoot id='3AC33DBE57'></tfoot></center><abbr id='3AC33DBE57'><dir id='3AC33DBE57'><tfoot id='3AC33DBE57'></tfoot><noframes id='3AC33DBE57'>

    • <optgroup id='3AC33DBE57'><strike id='3AC33DBE57'><sup id='3AC33DBE57'></sup></strike><code id='3AC33DBE57'></code></optgroup>
        1. <b id='3AC33DBE57'><label id='3AC33DBE57'><select id='3AC33DBE57'><dt id='3AC33DBE57'><span id='3AC33DBE57'></span></dt></select></label></b><u id='3AC33DBE57'></u>
          <i id='3AC33DBE57'><strike id='3AC33DBE57'><tt id='3AC33DBE57'><pre id='3AC33DBE57'></pre></tt></strike></i>

          
          WSS
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          knowledge